Key Dates
- Board Meeting Date: Wednesday, November 4, 2026
- Trading Window Closure Period: October 1, 2026 to November 6, 2026 (both days inclusive)
Agenda Items
The Board of Directors will consider and approve:
- Unaudited Financial Results (Standalone) for the quarter and half year ended September 30, 2026
- Unaudited Financial Results (Consolidated) for the quarter and half year ended September 30, 2026
Document Availability
The intimation is available on:
- Company website: www.marksanspharma.com
- BSE Limited website: www.bseindia.com
- National Stock Exchange of India Limited website: www.nseindia.com
Financial Impact
Financial results for the quarter are pending board approval. No financial figures or impacts are disclosed in this intimation.